TUBERCULOSIS
Clinical trials for TUBERCULOSIS explained in plain language.
Never miss a new study
Get alerted when new TUBERCULOSIS trials appear
Sign up with your email to follow new studies for TUBERCULOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
BioNTech tests new TB vaccines in first human safety trial
⭐️ VACCINE ⭐️ CompletedThis early-stage trial tested the safety of two new tuberculosis vaccine candidates in healthy adults who had never received the standard BCG vaccine. Researchers gave 120 participants different dose levels of the experimental vaccines or a placebo to check for side effects and i…
Matched conditions: TUBERCULOSIS
Phase: PHASE1 • Sponsor: BioNTech SE • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 30, 2026 14:33 UTC
-
African trial tests lifesaving combo for vulnerable babies
Disease control CompletedThis study tested whether adding treatments for tuberculosis (TB) and cytomegalovirus (CMV) to standard pneumonia care improves survival in HIV-infected infants with severe pneumonia. Researchers in six African countries enrolled 563 hospitalized babies aged 1-12 months. Infants …
Matched conditions: TUBERCULOSIS
Phase: PHASE2, PHASE3 • Sponsor: Hospital Universitario 12 de Octubre • Aim: Disease control
Last updated Apr 03, 2026 22:40 UTC
-
New drug combo tested to fight tuberculosis faster
Disease control CompletedThis study tested a new drug, GSK3036656, combined with other TB medications to see how quickly it could kill tuberculosis bacteria in the lungs over 14 days. It involved 127 adults newly diagnosed with drug-sensitive TB. After the 14-day test period, all participants switched ba…
Matched conditions: TUBERCULOSIS
Phase: PHASE2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
Scientists track TB drugs in body to find best dose for cure
Disease control CompletedThis study aimed to understand how the body processes high doses of two tuberculosis drugs, rifapentine and moxifloxacin. Researchers measured drug levels in the blood of 53 TB patients to see how these levels relate to how well the treatment works and its safety. The goal was to…
Matched conditions: TUBERCULOSIS
Phase: PHASE3 • Sponsor: Centers for Disease Control and Prevention • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
New hope for kids with Tough-to-Treat TB: safety study paves way for better dosing
Disease control CompletedThis study aimed to find safe and effective doses of the drug bedaquiline for children and adolescents with a hard-to-treat form of tuberculosis (TB) that resists standard antibiotics. It involved 54 young participants, from infants to teens, who also received their standard TB t…
Matched conditions: TUBERCULOSIS
Phase: PHASE1, PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Apr 02, 2026 14:58 UTC
-
Fortified cookies tested to boost Body's fight against TB
Disease control CompletedThis study tested whether eating cookies fortified with zinc and selenium could help improve the immune response in people being treated for tuberculosis. Researchers gave specially baked cookies to 90 tuberculosis patients to see if the added minerals would help their bodies fig…
Matched conditions: TUBERCULOSIS
Phase: NA • Sponsor: University of Lahore • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
Quick test aims to save children from hidden TB
Disease control CompletedThis study tested a new approach to find tuberculosis (TB) in young children hospitalized with severe pneumonia in six high-risk countries. Researchers wanted to see if using a fast, sensitive test on easy-to-collect samples (like nasal fluid and stool) right when a child arrives…
Matched conditions: TUBERCULOSIS
Phase: NA • Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Prison study tests faster TB prevention for vulnerable inmates
Disease control CompletedThis study tested two different approaches to prevent tuberculosis (TB) in Malaysian prisons, where many inmates have opioid addiction, HIV, or hepatitis. Researchers compared a standard 40-week daily treatment against a shorter 12-week weekly treatment to see which worked better…
Matched conditions: TUBERCULOSIS
Phase: NA • Sponsor: Yale University • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
Diabetes drug tested to fight TB and protect lungs in HIV patients
Disease control CompletedThis study tested whether adding the common diabetes medication metformin to standard antibiotic treatment for tuberculosis (TB) is safe and helps people recover better, especially for those also living with HIV. Researchers wanted to see if metformin could help clear the TB infe…
Matched conditions: TUBERCULOSIS
Phase: PHASE2 • Sponsor: University of Massachusetts, Worcester • Aim: Disease control
Last updated Mar 16, 2026 15:25 UTC
-
Breakthrough trial aims to slash death rates in vulnerable HIV/TB patients
Disease control CompletedThis large Phase 3 trial tested whether a stronger, intensified tuberculosis (TB) treatment regimen could save more lives than standard TB treatment in HIV patients hospitalized with TB and severely weakened immune systems (CD4 ≤ 100 cells/μL). It enrolled 1,330 adults and adoles…
Matched conditions: TUBERCULOSIS
Phase: PHASE3 • Sponsor: ANRS, Emerging Infectious Diseases • Aim: Disease control
Last updated Mar 12, 2026 13:51 UTC
-
Global push to spot hidden TB cases in Hard-to-Reach communities
Diagnosis CompletedThis study aimed to find better ways to diagnose tuberculosis (TB) in local clinics and among vulnerable groups. Researchers tested different combinations of simple TB tests on nearly 15,000 people across seven countries. The goal was to identify test packages that are accurate, …
Matched conditions: TUBERCULOSIS
Sponsor: Liverpool School of Tropical Medicine • Aim: Diagnosis
Last updated Apr 03, 2026 22:40 UTC
-
Your phone could soon diagnose your cough
Diagnosis CompletedThis study tested whether a smartphone app called Hyfe Cough Tracker could help monitor and manage coughs in people with various respiratory diseases. Over 600 participants with conditions like COPD, asthma, or COVID-19 used the app to record their coughs for up to 30 days. Resea…
Matched conditions: TUBERCULOSIS
Sponsor: Clinica Universidad de Navarra, Universidad de Navarra • Aim: Diagnosis
Last updated Apr 01, 2026 14:41 UTC
-
New TB screening combo aims to catch hidden cases cheaper
Diagnosis CompletedThis study tested two ways to screen for tuberculosis (TB) in communities in South Africa and Lesotho, where many cases go undiagnosed. It compared using a chest X-ray analysis software alone against combining that software with a simple blood test, before confirming any suspecte…
Matched conditions: TUBERCULOSIS
Phase: NA • Sponsor: Klaus Reither • Aim: Diagnosis
Last updated Mar 30, 2026 14:35 UTC
-
Poop test could revolutionize TB diagnosis for vulnerable kids
Diagnosis CompletedThis study tested a new, easier way to diagnose tuberculosis (TB) using a stool sample instead of hard-to-get sputum. It focused on young children and people living with HIV in Mozambique, Eswatini, and Uganda, where TB is common. The goal was to see if this simpler test could he…
Matched conditions: TUBERCULOSIS
Sponsor: Barcelona Institute for Global Health • Aim: Diagnosis
Last updated Mar 30, 2026 14:34 UTC
-
Race against time: new tool aims to spot deadly TB in vulnerable kids
Diagnosis CompletedThis study aimed to create a faster, simpler way to diagnose tuberculosis (TB) in young children who are severely malnourished and hospitalized. Researchers in Uganda and Zambia tested a combination of easy-to-collect samples and scans to develop a scoring system. The goal was to…
Matched conditions: TUBERCULOSIS
Phase: NA • Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Diagnosis
Last updated Mar 17, 2026 13:09 UTC
-
Simple stamp could save thousands from TB
Prevention CompletedThis study tested a new way to help clinics prevent tuberculosis (TB) in people living with HIV. Researchers changed the clinic paperwork so that TB prevention medication was automatically included on a patient's prescription, and a doctor had to actively choose to remove it. The…
Matched conditions: TUBERCULOSIS
Phase: NA • Sponsor: Johns Hopkins University • Aim: Prevention
Last updated Apr 03, 2026 14:43 UTC
-
Home delivery boosts TB prevention success
Prevention CompletedThis study tested whether delivering tuberculosis (TB) prevention medicine directly to people's communities helps more people finish their full course of treatment compared to the standard method of requiring monthly clinic visits. It involved 301 adults in South Africa who were …
Matched conditions: TUBERCULOSIS
Phase: NA • Sponsor: University of Washington • Aim: Prevention
Last updated Mar 31, 2026 12:11 UTC
-
Massive TB screening study seeks hidden disease clues
Knowledge-focused CompletedThis study screened 5,694 people who had previously participated in a vaccine trial to find cases of tuberculosis, including hidden infections without symptoms. Participants received chest x-rays and sputum tests, and researchers collected blood samples to look for biological mar…
Matched conditions: TUBERCULOSIS
Sponsor: COVID-19 Prevention Network • Aim: Knowledge-focused
Last updated Apr 03, 2026 22:41 UTC
-
Scientists test new way to speed up TB research in humans
Knowledge-focused CompletedThis study aimed to develop a new, faster method for testing future tuberculosis (TB) drugs and vaccines. Twenty healthy volunteers received a small, safe skin injection of the BCG vaccine (a weakened TB-related germ). Researchers then took skin samples to see how the body reacte…
Matched conditions: TUBERCULOSIS
Phase: PHASE1 • Sponsor: Fred Hutchinson Cancer Center • Aim: Knowledge-focused
Last updated Apr 02, 2026 14:57 UTC
-
Scientists test TB drug safety in weakened kidneys
Knowledge-focused CompletedThis study aimed to understand how a tuberculosis drug called pretomanid is processed by the body in people with different levels of kidney function. It involved 12 participants, some with healthy kidneys and some with mild to severe kidney impairment. Each person received a sing…
Matched conditions: TUBERCULOSIS
Phase: PHASE1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Apr 02, 2026 14:57 UTC
-
Scientists track drug safety for moms and babies
Knowledge-focused CompletedThis study aimed to understand how the body processes HIV and tuberculosis medications during pregnancy and after birth. Researchers observed 205 pregnant and breastfeeding women who were already taking these medications for their health care. They measured drug levels in the mot…
Matched conditions: TUBERCULOSIS
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:41 UTC
-
Chatbots and spit tests: a new approach to stop TB spread
Knowledge-focused CompletedThis study tested a new strategy to find people exposed to tuberculosis (TB) in Colombia. Researchers used a mobile app (chatbot) to communicate with patients and their household contacts and collected oral swabs for testing instead of traditional sputum samples. The main goal wa…
Matched conditions: TUBERCULOSIS
Phase: NA • Sponsor: Yale University • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:34 UTC
-
Scientists probe hidden links between hunger, parasites and TB
Knowledge-focused CompletedThis study aimed to understand why some people exposed to tuberculosis bacteria get sick while others don't. Researchers in India examined how malnutrition and worm infections affect the immune system's ability to fight TB. They studied 786 household contacts of TB patients, meas…
Matched conditions: TUBERCULOSIS
Phase: NA • Sponsor: Boston Medical Center • Aim: Knowledge-focused
Last updated Mar 20, 2026 14:48 UTC
-
Scientists use scans to watch TB drug travel through patients
Knowledge-focused CompletedThis small study aimed to understand how a tuberculosis drug, pretomanid, moves through and concentrates in the bodies of patients. Researchers used a special PET scan to track a tiny, safe amount of a radioactive version of the drug in 10 people with TB. The goal was to see if t…
Matched conditions: TUBERCULOSIS
Sponsor: Johns Hopkins University • Aim: Knowledge-focused
Last updated Mar 16, 2026 15:24 UTC